Abstract
Interest in the effectiveness of psychological interventions in patients with psychosis has increased in the last 2 decades, and early intervention programs are increasingly common. PIENSA (Programa de Intervención en Psicosis Adolescente; Intervention Program for Adolescent Psychosis) is a clinical program and pilot study based on previous research into the efficacy of early intervention in preventing relapse and improving outcome in patients with first-episode psychosis.
We describe a psychoeducational intervention designed for adolescents with early-onset psychosis and their parents. The intervention is adapted from McFarlane’s Multiple Family Therapy model to our setting and population (adolescents treated in the Spanish public health system). It consists of 2 stages: an individual stage comprising 3 sessions and a subsequent group stage comprising 12 sessions. The total program lasts for 1 academic year (9 months).
We present the design of our program and our preliminary experience in a Child and Adolescent Unit in Spain.
Keywords: Adolescents, family intervention, group therapy, psychoeducational, psychosis, treatment.
Adolescent Psychiatry
Title:PIENSA: Development of an Early Intervention Program for Adolescents With Early-Onset Psychosis and Their Families
Volume: 2 Issue: 3
Author(s): Ana Ruiz-Sancho, Ana Calvo, Marta Rapado-Castro, Miguel Moreno, Carmen Moreno, Teresa Sanchez-Gutierrez, Cecilia Tapia, Guadalupe Chiclana, Pamela Rodriguez, Patricia Fernandez, Celso Arango and Maria Mayoral
Affiliation:
Keywords: Adolescents, family intervention, group therapy, psychoeducational, psychosis, treatment.
Abstract: Interest in the effectiveness of psychological interventions in patients with psychosis has increased in the last 2 decades, and early intervention programs are increasingly common. PIENSA (Programa de Intervención en Psicosis Adolescente; Intervention Program for Adolescent Psychosis) is a clinical program and pilot study based on previous research into the efficacy of early intervention in preventing relapse and improving outcome in patients with first-episode psychosis.
We describe a psychoeducational intervention designed for adolescents with early-onset psychosis and their parents. The intervention is adapted from McFarlane’s Multiple Family Therapy model to our setting and population (adolescents treated in the Spanish public health system). It consists of 2 stages: an individual stage comprising 3 sessions and a subsequent group stage comprising 12 sessions. The total program lasts for 1 academic year (9 months).
We present the design of our program and our preliminary experience in a Child and Adolescent Unit in Spain.
Export Options
About this article
Cite this article as:
Ruiz-Sancho Ana, Calvo Ana, Rapado-Castro Marta, Moreno Miguel, Moreno Carmen, Sanchez-Gutierrez Teresa, Tapia Cecilia, Chiclana Guadalupe, Rodriguez Pamela, Fernandez Patricia, Arango Celso and Mayoral Maria, PIENSA: Development of an Early Intervention Program for Adolescents With Early-Onset Psychosis and Their Families, Adolescent Psychiatry 2012; 2 (3) . https://dx.doi.org/10.2174/2210676611202030229
DOI https://dx.doi.org/10.2174/2210676611202030229 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Commentary [Research Highlights : Neurotrophic Factor Treatment of Neurological Disorders: The Benefits of a Pleiotropic Treatment Approach]
CNS & Neurological Disorders - Drug Targets Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics
Current Neuropharmacology Micro- and Nano-particulate Strategies for Antigen Specific Immune Tolerance to Treat Autoimmune Diseases
Pharmaceutical Nanotechnology A Novel Immunotherapy for Alzheimers Disease: Antibodies against the β-Secretase Cleavage Site of APP
Current Alzheimer Research New Approaches to Target Cancer Stem Cells: Current Scenario
Mini-Reviews in Medicinal Chemistry EDITORIAL "Transplant Psychiatry"
Current Psychiatry Reviews Cell Type Specific Redox Status is Responsible for Diverse Electromagnetic Field Effects
Current Medicinal Chemistry The Framingham Brain Donation Program: Neuropathology Along the Cognitive Continuum
Current Alzheimer Research Vasopressin Antagonists as Anxiolytics and Antidepressants: Recent Developments
Recent Patents on CNS Drug Discovery (Discontinued) Dry Age-Related Macular Degeneration: Recent Progress of Therapeutic approaches
Current Molecular Pharmacology Evidence-Based Pharmacological Treatment of Substance Use Disorders and Pathological Gambling
Current Drug Abuse Reviews Alzheimer's Disease Prevention and Use of Traditional Plant Medicines
Letters in Drug Design & Discovery The Possibilities and Pitfalls for Anti-Complement Therapies in Inflammatory Diseases
Current Drug Targets - Inflammation & Allergy Dependence of DPPH Radical Scavenging Activity of Dietary Flavonoid Quercetin on Reaction Environment
Mini-Reviews in Medicinal Chemistry Urinary Steroid Measurements in Some Endocrine and Psychiatric Diseases
Current Medicinal Chemistry Enzyme Inhibition and Induction in Liver Disease
Current Clinical Pharmacology Efficacy of Adjunctive Brexpiprazole in Patients with Major Depressive Disorder: A Clinical Overview
Current Psychiatry Reviews Recent Advances in the Molecular Pathogenesis of Dystonia-Plus Syndromes and Heredodegenerative Dystonias
Current Neuropharmacology Circulating Advanced Oxidation Protein Products as Oxidative Stress Biomarkers and Progression Mediators in Pathological Conditions Related to Inflammation and Immune Dysregulation
Current Medicinal Chemistry Pharmacological Treatment of Obesity, Food Intake, and Reversal of Metabolic Disorders
Current Nutrition & Food Science